Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation

Медицинский совет

IS Yavelov¹ 

[1] Pirogov Russian National Research Medical University, Moscow;

关键词: ишемический инсульт;    тромбоэмболии;    антикоагулянты;    дабигатрана этексилат;    варфарин;    ischemic stroke;    thromboembolism;    anticoagulant;    dabigatran etexilate;    warfarin;   

DOI  :  10.21518/2079-701X-2014-12-33-39

来源: DOAJ

【 摘 要 】

Cardioembolic complications such as ischemic stroke and non-central nervous system venous thrombosis are among the most serious consequences of atrial fibrillation (AF) [1, 2]. The most effective way to prevent the complications is a long-term (indefinitely long) administration of anticoagulants, which, according to modern beliefs, are indicated in patients with atrial fibrillation with additional risk factors for cardiovascular complications.

【 授权许可】

Unknown